{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:13:00Z","timestamp":1778868780498,"version":"3.51.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1012905415868","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T15:14:19Z","timestamp":1040656459000},"page":"139-150","source":"Crossref","is-referenced-by-count":74,"title":["Current management of prolactinomas"],"prefix":"10.1007","volume":"54","author":[{"given":"Panos","family":"Nomikos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Fahlbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"358617_CR1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM198101153040306","volume":"304","author":"GN Burrow","year":"1981","unstructured":"Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K: Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 304: 156\u2013158, 1981","journal-title":"N Engl J Med"},{"key":"358617_CR2","first-page":"196","volume":"113","author":"M Riedel","year":"1986","unstructured":"Riedel M, Noldus J, Saeger W, Ludecke DK: Sellar lesions associated with isolated hyperprolactinaemia. Morphological, immunocytochemical, hormonal and clinical results. Acta Endocrinol (Copenh.) 113: 196\u2013203, 1986","journal-title":"Morphological, immunocytochemical, hormonal and clinical results. Acta Endocrinol (Copenh.)"},{"key":"358617_CR3","first-page":"179","volume-title":"Diagnosis and Treatment of Pituitary Tumors","author":"J Hardy","year":"1972","unstructured":"Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT (eds) Diagnosis and Treatment of Pituitary Tumors. Excerpta Media, Amsterdam, 1972, pp 179\u2013194"},{"key":"358617_CR4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bmj.3.5828.669","volume":"2","author":"GM Besser","year":"1972","unstructured":"Besser GM, Parke L, Edwards CRW, Forsythe IA, MacNeilly AS: Galactorrhea; successful treatment with reduction of plasma prolactin levels by bromocriptine. Br Med J 2: 669\u2013672, 1972","journal-title":"Br Med J"},{"key":"358617_CR5","first-page":"103","volume-title":"Second European Workshop on Pituitary Adenomas","author":"SJ Nillius","year":"1980","unstructured":"Nillius SJ, Bergh T, Larsson SG: Pituitary tumors and pregnancy. In: Derome P, Jedynak CP, Peillon F (eds) Second European Workshop on Pituitary Adenomas. Asclepios France, Paris, 1980, pp 103\u2013112"},{"key":"358617_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1210\/jcem-67-1-116","volume":"67","author":"JD Veldhuis","year":"1988","unstructured":"Veldhuis JD, Johnson ML: Operating characteristics of the hypothalamo-pituitary-gonadal axis in men: circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 67: 116\u2013123, 1988","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR7","first-page":"221","volume-title":"Williams Textbook of Endocrinology","author":"MO Thorner","year":"1992","unstructured":"Thorner MO, Vance ML, Horvath E, Kovacs K: The anterior pituitary. In: Wilson JD, Foster DW (eds) Williams Textbook of Endocrinology. WB Saunders, Philadelphia, 1992, pp 221\u2013311"},{"key":"358617_CR8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0889-8529(18)30461-4","volume":"16","author":"RM Lechan","year":"1987","unstructured":"Lechan RM: Neuroendocrinology of pituitary hormone regulation. Endocrinol Metab Clin North Am 16: 475\u2013501, 1987","journal-title":"Endocrinol Metab Clin North Am"},{"key":"358617_CR9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/316511a0","volume":"316","author":"K Nikolics","year":"1985","unstructured":"Nikolics K, Mason AJ, Szonyi E, Ramachandran J, Seeburg PH: A prolactin-inhibiting factor within the precursor for human gonadotropin-releasing hormone. Nature 316: 511\u2013517, 1985","journal-title":"Nature"},{"key":"358617_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00006123-199608000-00008","volume":"39","author":"T O'Brien","year":"1996","unstructured":"O'Brien T, O'Riordan DS, Gharib H, Scheithauer BW, Ebersold MJ, van Heerden JA: Results of treatment of pituitary disease in multiple endocrine neoplasia, type I. Neurosurgery 39: 273\u2013278, 1996","journal-title":"Neurosurgery"},{"key":"358617_CR11","first-page":"4","volume":"22","author":"K Thapar","year":"1995","unstructured":"Thapar K, Kovacs K, Laws ER: The classification and molecular biology of pituitary adenomas. Adv Tech Stand Neurosurg 22: 4\u201353, 1995","journal-title":"Adv Tech Stand Neurosurg"},{"key":"358617_CR12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/jcem-71-6-1427","volume":"71","author":"V Herman","year":"1990","unstructured":"Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427\u20131433, 1990","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR13","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1073\/pnas.87.5.1968","volume":"87","author":"C Bystrom","year":"1990","unstructured":"Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S, Nordenskjold M: Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87: 1968\u20131972, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"358617_CR14","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/1097-0142(19811101)48:9<2029::AID-CNCR2820480920>3.0.CO;2-N","volume":"48","author":"PU Heitz","year":"1981","unstructured":"Heitz PU, Kloppel G, Polak JM, Staub JJ: Ectopic hormone production by endocrine tumors: localization of hormones at the cellular level by immunocytochemistry. Cancer 48: 2029\u20132037, 1981","journal-title":"Cancer"},{"key":"358617_CR15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000126575","volume":"58","author":"SK Park","year":"1993","unstructured":"Park SK, Keanan MW, Selmanoff M: Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated rats. Neuroendocrinology 58: 448\u2013453, 1993","journal-title":"Neuroendocrinology"},{"key":"358617_CR16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.1986.tb03282.x","volume":"24","author":"DW Polson","year":"1986","unstructured":"Polson DW, Sagle M, Mason HD, Adams J, Jacobs HS, Franks S: Ovulation and normal luteal function during LHRHtreatment ofwomen with hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) 24: 531\u2013537, 1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358617_CR17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jcem-67-1-124","volume":"67","author":"A Klibanski","year":"1988","unstructured":"Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V: Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 67: 124\u2013130, 1988","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR18","first-page":"832","volume":"42","author":"N Onoda","year":"1992","unstructured":"Onoda N, Kamezu Y, Takagi S, Shinohara Y, Osamura RY: An autopsy case of invasive pituitary adenoma (prolactinoma) with rapid fatal clinical course due to streptococcal meningitis. Acta Pathol Jpn 42: 832\u2013836, 1992","journal-title":"Acta Pathol Jpn"},{"key":"358617_CR19","first-page":"117","volume":"44","author":"ME Molitch","year":"1999","unstructured":"Molitch ME: Diagnosis and treatment of prolactinomas. Adv Intern Med 44: 117\u2013153, 1999","journal-title":"Adv Intern Med"},{"key":"358617_CR20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jcem-58-3-405","volume":"58","author":"L De Marinis","year":"1984","unstructured":"De Marinis L, Mancini A, Maira G, Anile C, Menini E, Barbarino A: Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide. J Clin Endocrinol Metab 58: 405\u2013409, 1984","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000125749","volume":"53","author":"L Persani","year":"1991","unstructured":"Persani L, Beck-Peccoz P, Medri G, Conti A, Faglia G: Thyrotropin alpha-and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas. Neuroendocrinology 53: 411\u2013415, 1991","journal-title":"Neuroendocrinology"},{"key":"358617_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.1986.tb01649.x","volume":"24","author":"MF Scanlon","year":"1986","unstructured":"Scanlon MF, Peters JR, Salvador J, Richards SH, John R, Howell S, Williams ED, Thomas JP, Hall R: The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery. Clin Endocrinol (Oxf) 24: 435\u2013446, 1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358617_CR23","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C: Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33: 610\u2013617, 1993","journal-title":"Neurosurgery"},{"key":"358617_CR24","first-page":"132","volume-title":"Pituitary Adenomas","author":"M Buchfelder","year":"1996","unstructured":"Buchfelder M, Fahlbusch R, Nomikos P, et al.: Recent advances in CT and MRI in the diagnosis and followup of hypothalamo-pituitary disease. In: von Werder K, Fahlbusch R (eds) Pituitary Adenomas. Excerpta Medica Elsevier, Amsterdam, 1996, pp 132\u2013145"},{"key":"358617_CR25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0002-9378(81)90553-6","volume":"139","author":"CM March","year":"1981","unstructured":"March CM, Kletzky OA, Davajan V, Teal J, Weiss M, Apuzzo ML, Marrs RP, Mishell DR: Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 139: 835\u2013844, 1981","journal-title":"Am J Obstet Gynecol"},{"key":"358617_CR26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jcem-68-2-412","volume":"68","author":"J Schlechte","year":"1989","unstructured":"Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A: The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68: 412\u2013418, 1989","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1227\/00006123-198302000-00008","volume":"12","author":"MH Weiss","year":"1983","unstructured":"Weiss MH, Teal J, Gott P, Wycoff R, Yardley R, Apuzzo MLJ, Giannota SL, Kletzky O, March C: Natural history of microprolactinomas: six-year follow-up. Neurosurgery 12: 180\u2013183, 1983","journal-title":"Neurosurgery"},{"key":"358617_CR28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jcem-35-5-768","volume":"35","author":"E DelPozo","year":"1972","unstructured":"DelPozo E, Del Re RB, Varga L, Friesen H: The inhibition of prolactin secretion in man by CB-154 (2-Br-alphaergocryptine). J Clin Endocrinol Metab 35: 768\u2013771, 1972","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/jama.1982.03320280031025","volume":"247","author":"RF Spark","year":"1982","unstructured":"Spark RF, Baker R, Bienfang DC, Bergland R: Bromocriptine reduces pituitary tumor size and hypersection. Requiem for pituitary surgery? JAMA 247: 311\u2013316, 1982","journal-title":"JAMA"},{"key":"358617_CR30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2265.1978.tb01506.x","volume":"9","author":"L De Cecco","year":"1978","unstructured":"De Cecco L, Foglia G, Ragni N, Rossato P, Venturini PL: The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses. Clin Endocrinol (Oxf) 9: 491\u2013498, 1978","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358617_CR31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(81)90997-1","volume":"2","author":"S Franks","year":"1981","unstructured":"Franks S, Horrocks PM, Lynch SS, Butt WR, London DR: Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment. Lancet 2: 659\u2013661, 1981","journal-title":"Lancet"},{"key":"358617_CR32","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/jcem-63-4-1002","volume":"63","author":"D Dallabonzana","year":"1986","unstructured":"Dallabonzana D, Liuzzi A, Oppizzi G, Cozzi R, Verde G, Chiodini P, Rainer E, Dorow R, Horowski R: Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride. J Clin Endocrinol Metab 63: 1002\u20131007, 1986","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(88)90696-6","volume":"151","author":"A Dall'Ara","year":"1988","unstructured":"Dall'Ara A, Lima L, Cocchi D, Di Salle E, Cancio E, Devesa J, Muller EE: Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary. Eur J Pharmacol 151: 97\u2013102, 1988","journal-title":"Eur J Pharmacol"},{"key":"358617_CR34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jcem-63-4-941","volume":"63","author":"C Ferrari","year":"1986","unstructured":"Ferrari C, Barbieri C, Caldara R, Mucci M, Codecasa F, Paracchi A, Romano C, Boghen M, Dubini A: Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients. J Clin Endocrinol Metab 63: 941\u2013945, 1986","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jcem-68-2-336","volume":"68","author":"ML Vance","year":"1989","unstructured":"Vance ML, Cragun JR, Reimnitz C, Chang RJ, Rashef E, Blackwell RE, Miller MM, Molitch ME: CV 205-502 treatment of hyperprolactinemia. J Clin Endocrinol Metab 68: 336\u2013339, 1989","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2265.1987.tb00789.x","volume":"26","author":"C Rasmussen","year":"1987","unstructured":"Rasmussen C, Bergh T, Wide L, Brownell J: CV 205-502: a new long-acting drug for inhibition of prolactin hypersecretion. Clin Endocrinol (Oxf) 26: 321\u2013326, 1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358617_CR37","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1016\/S0021-9258(19)70612-7","volume":"255","author":"RA Maurer","year":"1980","unstructured":"Maurer RA: Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem 255: 8092\u20138097, 1980","journal-title":"J Biol Chem"},{"key":"358617_CR38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jcem-60-4-698","volume":"60","author":"ME Molitch","year":"1985","unstructured":"Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO: Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 60: 698\u2013705, 1985","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1210\/jcem-55-6-1178","volume":"55","author":"GT Tindall","year":"1982","unstructured":"Tindall GT, Kovacs K, Horvath E, Thorner MO: Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study. J Clin Endocrinol Metab 55: 1178\u20131183, 1982","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-58-6-1179","volume":"58","author":"AM Landolt","year":"1984","unstructured":"Landolt AM, Osterwalder V: Perivascular fibrosis in prolactinomas: is it increased by bromocriptine? J Clin Endocrinol Metab 58: 1179\u20131183, 1984","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2265.1987.tb00809.x","volume":"26","author":"JS Bevan","year":"1987","unstructured":"Bevan JS, Adams CB, Burke CW, Morton KE, Molyneux AJ, Moore RA, Esiri MM: Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy. Clin Endocrinol (Oxf) 26: 541\u2013556, 1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358617_CR42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(82)92756-8","volume":"2","author":"AM Landolt","year":"1982","unstructured":"Landolt AM, Keller PJ, Froesch ER, Mueller J: Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas? Lancet 2: 657\u2013658, 1982","journal-title":"Lancet"},{"key":"358617_CR43","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0889-8529(18)30471-7","volume":"16","author":"ML Vance","year":"1987","unstructured":"Vance ML, Thorner MO: Prolactinomas. Endocrinol Metab Clin North Am 16: 731\u2013753, 1987","journal-title":"Endocrinol Metab Clin North Am"},{"key":"358617_CR44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0889-8529(18)30193-2","volume":"21","author":"ME Molitch","year":"1992","unstructured":"Molitch ME: Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am 21: 877\u2013901, 1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"358617_CR45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","volume":"13","author":"JS Bevan","year":"1992","unstructured":"Bevan JS, Webster J, Burke CW, Scanlon MF: Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13: 220\u2013240, 1992","journal-title":"Endocr Rev"},{"key":"358617_CR46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/jcem-69-3-500","volume":"69","author":"I Pellegrini","year":"1989","unstructured":"Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP, Kordon C, Peillon F, Jaquet P, Enjalbert A: Resistance to bromocriptine in prolactinomas. J Clin Endocrinol Metab 69: 500\u2013509, 1989","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR47","first-page":"581","volume":"2","author":"JG Klijn","year":"1979","unstructured":"Klijn JG, Lamberts SW, Birkenhager JC: TRH test for prolactinoma. Lancet 2: 581\u2013582, 1979","journal-title":"Lancet"},{"issue":"6","key":"358617_CR48","first-page":"2247","volume":"85","author":"A Colao","year":"2000","unstructured":"Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, Di Salle F, Cirillo S, Annunziato L, Lombardi G: Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab 85(6): 2247\u20132252; 85: 2247-2252, 2000","journal-title":"J Clin Endocrinol Metab"},{"key":"358617_CR49","unstructured":"Nomikos P, Fahlbusch R, Buchfelder M: Macroprolactinomas: Persistent normoprolactinemia and disappearence of tumour on MR images after short-term medical treatment with dopamine agonists. Exp Clin Endocrinol Diabetes 108: 193\u20132000"},{"key":"358617_CR50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01456167","volume":"96","author":"G Hildebrandt","year":"1989","unstructured":"Hildebrandt G, Zierski J, Christophis P, Laun A, Schatz H, Lancranjan I, Klug N: Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma. Acta Neurochir (Wien) 96: 107\u2013113, 1989","journal-title":"Acta Neurochir (Wien)"},{"key":"358617_CR51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1212\/WNL.34.1.111","volume":"34","author":"RO Holness","year":"1984","unstructured":"Holness RO, Shlossberg AH, Heffernan LP: Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma. Neurology 34: 111\u2013113, 1984","journal-title":"Neurology"},{"issue":"5","key":"358617_CR52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2265.2000.01147.x","volume":"53","author":"J Webster","year":"2000","unstructured":"Webster J: Cabergoline and quinagolide therapy for prolactinomas. Clin Endocrinol (Oxf) 53(5): 549\u2013550; 53: 549-550, 2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358617_CR53","first-page":"105","volume-title":"Perspectives in Neurological Surgery","author":"AM Landolt","year":"1990","unstructured":"Landolt AM: Prolactinomas: preoperative bromocriptine treatment. Surgical results. In: Barrow DL (eds) Perspectives in Neurological Surgery. Quality Medical Publishing, St. Louis, 1990, pp 105\u2013115"},{"key":"358617_CR54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-3-7091-9450-8","volume-title":"Pituitary Adenomas","author":"R Fahlbusch","year":"1996","unstructured":"Fahlbusch R, Buchfelder M: Surgical complications. In: Landolt AM, Vance ML, Reilly PL (eds) Pituitary Adenomas. Churchill Livingstone, NewYork, 1996, pp 395\u2013408"},{"key":"358617_CR55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/neurosurgery\/23.CN_suppl_1.401","volume":"23","author":"ER Laws","year":"1976","unstructured":"Laws ER, Kern EB: Complications of trans-sphenoidal surgery. Clin Neurosurg 23: 401\u2013416, 1976","journal-title":"Clin Neurosurg"},{"key":"358617_CR56","first-page":"377","volume-title":"Secretor Tumors of the Pituitary Gland","author":"NT Zervas","year":"1984","unstructured":"Zervas NT: Surgical results for pituitary adenomas: Results of an international survey. In: Black PM, Zervas NT, Ridgway EC, Martin JB (eds) Secretor Tumors of the Pituitary Gland. Raven Press, New York, 1984, pp 377\u2013385"},{"key":"358617_CR57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3171\/jns.1982.56.1.0033","volume":"56","author":"MA Faria","year":"1982","unstructured":"Faria MA, Tindall GT: Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas. J Neurosurg 56: 33\u201343, 1982","journal-title":"J Neurosurg"},{"key":"358617_CR58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0002-9378(80)90392-0","volume":"137","author":"JN Domingue","year":"1980","unstructured":"Domingue JN, Richmond IL, Wilson CB: Results of surgery in 114 patients with prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 137: 102\u2013108, 1980","journal-title":"Am J Obstet Gynecol"},{"key":"358617_CR59","first-page":"141","volume":"14","author":"PR Aubourg","year":"1980","unstructured":"Aubourg PR, Derome PJ, Peillon F, Jedynak CP, Visot A, Le Gentil P, Balagura S, Guiot G: Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumor size as predicting factors. Surg Neurol 14: 141\u2013143, 1980","journal-title":"Surg Neurol"},{"key":"358617_CR60","first-page":"361","volume-title":"Progress in Prolactin Physiology and Pathology","author":"J Hardy","year":"1978","unstructured":"Hardy J, Beauregard H, Robert F: Prolactin-secreting pituitary adenomas: transsphenoidal microsurgical treatment. In: Robyn C, Harter M (eds) Progress in Prolactin Physiology and Pathology. Elsevier\/North-Holland Biomedical Press, Amsterdam, 1978, pp 361\u2013370"},{"key":"358617_CR61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2214\/ajr.146.2.257","volume":"146","author":"J Ahmadi","year":"1986","unstructured":"Ahmadi J, North CM, Segall HD, Zee CS, Weiss MH: Cavernous sinus invasion by pituitary adenomas. AJR Am J Roentgenol 146: 257\u2013262, 1986","journal-title":"AJR Am J Roentgenol"},{"key":"358617_CR62","first-page":"18","volume":"65","author":"M Buchfelder","year":"1996","unstructured":"Buchfelder M, Fahlbusch R, Adams EF, Kiesewetter F, Thierauf P: Proliferation parameters for pituitary adenomas. Acta Neurochir Suppl (Wien) 65: 18\u201321, 1996","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"358617_CR63","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3171\/jns.1988.68.4.0554","volume":"68","author":"DL Barrow","year":"1988","unstructured":"Barrow DL, Mizuno J, Tindall GT: Management of prolactinomas associated with very high serum prolactin levels. J Neurosurg 68: 554\u2013558, 1988","journal-title":"J Neurosurg"},{"key":"358617_CR64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(83)91782-8","volume":"1","author":"G Faglia","year":"1983","unstructured":"Faglia G, Moriondo P, Travaglini P, Giovanelli MA: Influence of previous bromocriptine therapy on surgery for microprolactinoma. Lancet 1: 133\u2013134, 1983","journal-title":"Lancet"},{"key":"358617_CR65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0344-0338(11)80151-2","volume":"187","author":"G Perrin","year":"1991","unstructured":"Perrin G, Treluyer C, Trouillas J, Sassolas G, Goutelle A: Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas. Pathol Res Pract 187: 587\u2013592, 1991","journal-title":"Pathol Res Pract"},{"key":"358617_CR66","doi-asserted-by":"crossref","unstructured":"Fahlbusch R, Buchfelder M, Schrell U: Short-term preoperative treatment of macroprolactinomas by dopamine agonists. J Neurosurg 807\u2013815, 1987","DOI":"10.3171\/jns.1987.67.6.0807"},{"key":"358617_CR67","first-page":"443","volume-title":"Pituitary Microadenomas","author":"R Fahlbusch","year":"1980","unstructured":"Fahlbusch R, Giovanelli M, Crosignani P, Faglia G, Rjosk HK, von Werder K: Differentiated therapy of microprolactinomas: Significance of transsphenoidal adenomectomy. In: Faglia G, Giovanelli M, McLeod R (eds) Pituitary Microadenomas. Academic Press, London, 1980, pp 443\u2013457"},{"key":"358617_CR68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7326\/0003-4819-94-3-302","volume":"94","author":"HS Tucker","year":"1981","unstructured":"Tucker HS, Grubb SR, Wigand JP, Taylon A, Lankford HV, Blackard WG, Becker DP: Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal. Ann Intern Med 94: 302\u2013307, 1981","journal-title":"Ann Intern Med"},{"key":"358617_CR69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198308043090505","volume":"309","author":"O Serri","year":"1983","unstructured":"Serri O, Rasio E, Beauregard H, Hardy J, Somma M: Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med 309: 280\u2013283, 1983","journal-title":"N Engl J Med"},{"key":"358617_CR70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01815444","volume":"8","author":"R Fahlbusch","year":"1985","unstructured":"Fahlbusch R, Buchfelder M: Present status of neurosurgery in the treatment of prolactinomas. Neurosurg Rev 8: 195\u2013205, 1985","journal-title":"Neurosurg Rev"},{"key":"358617_CR71","first-page":"3","volume-title":"Pituitary Adenomas: From Basic Research to Diagnosis and Therapy","author":"ER Laws","year":"1996","unstructured":"Laws ER, Chenelle AG, Thapar K: Recurrence after transsphenoidal surgery for pituitary adenomas. In: Fahlbusch R, von Werder K (eds) Pituitary Adenomas: From Basic Research to Diagnosis and Therapy. Elsevier, Amsterdam, 1996, pp 3\u20139"},{"key":"358617_CR72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0360-3016(89)90384-2","volume":"17","author":"SC Rush","year":"1989","unstructured":"Rush SC, Newall J: Pituitary adenoma: the efficacy of radiotherapy as the sole treatment. Int J Radiat Oncol Biol Phys 17: 165\u2013169, 1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"358617_CR73","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2265.1991.tb00312.x","volume":"34","author":"S Tsagarakis","year":"1991","unstructured":"Tsagarakis S, Grossman A, Plowman PN, Jones AE, Touzel R, Rees LH, Wass JA, Besser GM: Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up. Clin Endocrinol (Oxf) 34: 399\u2013406, 1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358617_CR74","doi-asserted-by":"crossref","unstructured":"Grossman A, Besser M, Wass J, Rees L: Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed) 288: 2002\u20131984","DOI":"10.1136\/bmj.288.6435.2002"},{"issue":"3","key":"358617_CR75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3171\/jns.2000.93.supplement_3.0014","volume":"93","author":"AM Landolt","year":"2000","unstructured":"Landolt AM, Lomax N: Gamma knife radiosurgery for prolactinomas. J Neurosurg 93(3): 14\u201318, 2000","journal-title":"J Neurosurg"},{"key":"358617_CR76","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198505233122106","volume":"312","author":"ME Molitch","year":"1985","unstructured":"Molitch ME: Pregnancy and the hyperprolactinemicwoman. N Engl J Med 312: 1364\u20131370, 1985","journal-title":"N Engl J Med"},{"key":"358617_CR77","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF01727477","volume":"65","author":"P Krupp","year":"1987","unstructured":"Krupp P, Monka C: Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 65: 823\u2013827, 1987","journal-title":"Klin Wochenschr"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012905415868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1012905415868\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012905415868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:18:42Z","timestamp":1749633522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1012905415868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["358617"],"URL":"https:\/\/doi.org\/10.1023\/a:1012905415868","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}